Jacky Woo

1.3k total citations
40 papers, 922 citations indexed

About

Jacky Woo is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Jacky Woo has authored 40 papers receiving a total of 922 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Immunology, 14 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Jacky Woo's work include Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (8 papers) and T-cell and B-cell Immunology (8 papers). Jacky Woo is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (8 papers) and T-cell and B-cell Immunology (8 papers). Jacky Woo collaborates with scholars based in United States, United Kingdom and France. Jacky Woo's co-authors include Roland Buelow, Suhasini Iyer, Lan Gao, Angus W. Thomson, Mahin D. Maines, Abdul S. Rao, Thomas E. Starzl, Lina Lü, Youping Li and Владимир Субботин and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Blood.

In The Last Decade

Jacky Woo

38 papers receiving 888 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacky Woo United States 15 355 306 193 144 141 40 922
Michaëla Semeraro France 17 224 0.6× 276 0.9× 141 0.7× 97 0.7× 126 0.9× 34 989
Nirmala Parajuli United States 13 224 0.6× 168 0.5× 121 0.6× 76 0.5× 134 1.0× 25 638
Milton G. Mutchnick United States 20 180 0.5× 199 0.7× 703 3.6× 645 4.5× 162 1.1× 78 1.4k
Kentaro Watanabe Japan 17 369 1.0× 101 0.3× 92 0.5× 37 0.3× 165 1.2× 77 1.2k
Takayuki Iwaki Japan 18 202 0.6× 183 0.6× 111 0.6× 15 0.1× 92 0.7× 44 1.1k
Cheng Ding China 18 334 0.9× 179 0.6× 215 1.1× 111 0.8× 90 0.6× 37 942
Martin Leníček Czechia 20 490 1.4× 80 0.3× 366 1.9× 153 1.1× 334 2.4× 65 1.2k
Sebastian Hinz Germany 17 408 1.1× 366 1.2× 159 0.8× 89 0.6× 231 1.6× 41 1.3k
Jing Cao China 20 516 1.5× 107 0.3× 192 1.0× 76 0.5× 79 0.6× 67 1.2k

Countries citing papers authored by Jacky Woo

Since Specialization
Citations

This map shows the geographic impact of Jacky Woo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacky Woo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacky Woo more than expected).

Fields of papers citing papers by Jacky Woo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacky Woo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacky Woo. The network helps show where Jacky Woo may publish in the future.

Co-authorship network of co-authors of Jacky Woo

This figure shows the co-authorship network connecting the top 25 collaborators of Jacky Woo. A scholar is included among the top collaborators of Jacky Woo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacky Woo. Jacky Woo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Belperio, John A., Tuan S. Nguyen, David A. Lombardi, et al.. (2023). Efficacy and safety of an inhaled pan-Janus kinase inhibitor, nezulcitinib, in hospitalised patients with COVID-19: results from a phase 2 clinical trial. BMJ Open Respiratory Research. 10(1). e001627–e001627. 5 indexed citations
3.
Janssen, Harry L.A., Maurizia Rossana Brunetto, Yoon Jun Kim, et al.. (2017). Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B. Journal of Hepatology. 68(3). 431–440. 142 indexed citations
4.
Li, Wei, Suhasini Iyer, Lina Lü, et al.. (2002). Attenuation of aortic graft arteriosclerosis by systemic administration of Allotrap peptide RDP58. Transplant International. 16(12). 849–856. 8 indexed citations
5.
Woo, Jacky, et al.. (2000). ALLEVIATION OF GRAFT-VERSUS-HOST DISEASE AFTER CONDITIONING WITH COBALT-PROTOPORPHYRIN, AN INDUCER OF HEME OXYGENASE-1. Transplantation. 69(4). 623–633. 43 indexed citations
6.
Iyer, Suhasini, et al.. (2000). Inhibition of Tumor Necrosis Factor mRNA Translation by a Rationally Designed Immunomodulatory Peptide. Journal of Biological Chemistry. 275(22). 17051–17057. 37 indexed citations
7.
Iyer, Suhasini, Jacky Woo, Lan Gao, et al.. (1998). Characterization and Biological Significance of Immunosuppressive Peptide D2702.75–84(E → V) Binding Protein. Journal of Biological Chemistry. 273(5). 2692–2697. 49 indexed citations
8.
Grassy, Gérard, Bernard Calas, Abdelaziz Yasri, et al.. (1998). Computer-assisted rational design of immunosuppressive compounds. Nature Biotechnology. 16(8). 748–752. 75 indexed citations
9.
Woo, Jacky, et al.. (1997). Immunosuppression By D-Isomers Of Hla Class I Heavy Chain (Amino Acid 75 To 84)-Derived Peptides Is Independent Of Binding To Hsc70. Transplantation. 64(10). 1460–1467. 19 indexed citations
11.
12.
Woo, Jacky, et al.. (1995). Isolation of Dendritic Leukocytes from Mouse Liver. Advances in experimental medicine and biology. 378. 543–548. 2 indexed citations
13.
Thomson, Angus W., et al.. (1995). Exposure to Type-I Collagen Induces Maturation of Mouse Liver Dendritic Cell Progenitors. Advances in experimental medicine and biology. 378. 511–518. 5 indexed citations
14.
Woo, Jacky, Lina Lü, Abdul S. Rao, et al.. (1994). ISOLATION, PHENOTYPE, AND ALLOSTIMULATORY ACTIVITY OF MOUSE LIVER DENDRITIC CELLS. Transplantation. 58(4). 484–491. 92 indexed citations
15.
Woo, Jacky, Suzanne T. Ildstad, & Angus W. Thomson. (1994). FK506 inhibits the differentiation of developing thymocytes but not negative selection of T cell receptor Vβ5+ and Vβ;11+ T lymphocytes in vivo. Transplant Immunology. 2(1). 11–21. 7 indexed citations
16.
Thomson, Angus W., Jacky Woo, Bonnie Lemster, et al.. (1993). Incidence of CD4+ IL‐2Rα+ and CD4+ CD45RA+ T‐Cells in Progressive Multiple Sclerosis and the Influence of Short‐Term (3 Months) FK 506 Therapy. Annals of the New York Academy of Sciences. 696(1). 245–246. 4 indexed citations
17.
Woo, Jacky, L A Valdivia, Fan Pan, et al.. (1993). Cytidine Potentiates the Inhibitory Effect of Brequinar Sodium on Xeno‐MLR, Antibody Production, and Concordant Hamster to Rat Cardiac Xenograft Survivala. Annals of the New York Academy of Sciences. 696(1). 227–234. 1 indexed citations
18.
Lemster, Bonnie, Jacky Woo, & Angus W. Thomson. (1993). Blood lymphocytes of autoimmune disease patients receiving FK506 exhibit normal ex vivo cytokine gene expression and proliferative responses. Immunology Letters. 38(3). 179–183. 1 indexed citations
19.
Propper, David, Jacky Woo, Alison M. MacLeod, Graeme Catto, & Angus W. Thomson. (1992). THE EFFECTS OF RAPAMYCIN ON HUMORAL IMMUNITY IN VIVO SUPPRESSION OF PRIMARY RESPONSES BUT NOT OF ONGOING ALLOANTIBODY SYNTHESIS OR MEMORY RESPONSES. Transplantation. 54(6). 1058–1063. 9 indexed citations
20.
Woo, Jacky & Angus W. Thomson. (1989). Alleviation of cyclosporin-induced immune suppression by the cytokine inducer ADA-202-718. Immunopharmacology. 17(2). 91–98. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026